Work

mRNA Vaccination for Treating Allergy by Modulating Allergen‐Specific Immunity

Year: 2026

Type: article

Abstract: This News and Views article discusses the rationale for anti-allergy vaccine development using a lipid nanoparticle-mRNA platform. The authors provide additional evidence that supports the potential of using the mRNA approach to combat allergic diseases.

Source: iLABMED

DOI: 10.1002/ila2.70047

Authors: Kun Guo, Lijing Liu, Mingyun Shen, Karin Loré, Ang Lin

Institutions: China Pharmaceutical University, Karolinska Institutet

Language: English

Topic: Allergic Rhinitis and Sensitization

Subfield: Immunology and Allergy

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: National Natural Science Foundation of China, Government of Jiangsu Province